Suppr超能文献

人尿苷二磷酸葡萄糖醛酸基转移酶(UGTs)对奥沙西泮的立体选择性结合:S-奥沙西泮由UGT2B15进行葡萄糖醛酸化,而R-奥沙西泮由UGT2B7和UGT1A9进行葡萄糖醛酸化。

Stereoselective conjugation of oxazepam by human UDP-glucuronosyltransferases (UGTs): S-oxazepam is glucuronidated by UGT2B15, while R-oxazepam is glucuronidated by UGT2B7 and UGT1A9.

作者信息

Court Michael H, Duan Su X, Guillemette Chantal, Journault Kim, Krishnaswamy Soundararajan, Von Moltke Lisa L, Greenblatt David J

机构信息

Comparative and Molecular Pharmacogenetics Laboratory, Department of Pharmacology and Experimental Therapeutics, Tufts University School of Medicine, Boston, Massachusetts 02111, USA.

出版信息

Drug Metab Dispos. 2002 Nov;30(11):1257-65. doi: 10.1124/dmd.30.11.1257.

Abstract

(R,S)-Oxazepam is a 1,4-benzodiazepine anxiolytic drug that is metabolized primarily by hepatic glucuronidation. In previous studies, S-oxazepam (but not R-oxazepam) was shown to be polymorphically glucuronidated in humans. The aim of the present study was to identify UDP-glucuronosyltransferase (UGT) isoforms mediating R- and S-oxazepam glucuronidation in human liver, with the long term objective of elucidating the molecular genetic basis for this drug metabolism polymorphism. All available recombinant UGT isoforms were screened for R- and S-oxazepam glucuronidation activities. Enzyme kinetic parameters were then determined in representative human liver microsomes (HLMs) and in UGTs that showed significant activity. Of 12 different UGTs evaluated, only UGT2B15 showed significant S-oxazepam glucuronidation. Furthermore, the apparent K(m) for UGT2B15 (29-35 microM) was similar to values determined for HLMs (43-60 microM). In contrast, R-oxazepam was glucuronidated by UGT1A9 and UGT2B7. Although apparent K(m) values for HLMs (256-303 microM) were most similar to UGT2B7 (333 microM) rather than UGT1A9 (12 microM), intrinsic clearance values for UGT1A9 were 10 times higher than for UGT2B7. A common genetic variation results in aspartate (UGT2B151) or tyrosine (UGT2B152) at position 85 of the UGT2B15 protein. Microsomes from human embryonic kidney (HEK)-293 cells overexpressing UGT2B151 showed 5 times higher S-oxazepam glucuronidation activity than did UGT2B152 microsomes. Similar results were obtained for other substrates, including eugenol, naringenin, 4-methylumbelliferone, and androstane-3alpha-diol. In conclusion, S-oxazepam is stereoselectively glucuronidated by UGT2B15, whereas R-oxazepam is glucuronidated by multiple UGT isoforms. Allelic variation associated with the UGT2B15 gene may explain polymorphic S-oxazepam glucuronidation in humans.

摘要

(R,S)-奥沙西泮是一种1,4-苯二氮䓬类抗焦虑药物,主要通过肝脏葡萄糖醛酸化进行代谢。在先前的研究中,S-奥沙西泮(而非R-奥沙西泮)在人体内表现出多态性葡萄糖醛酸化。本研究的目的是确定介导人肝脏中R-和S-奥沙西泮葡萄糖醛酸化的尿苷二磷酸葡萄糖醛酸基转移酶(UGT)同工型,其长期目标是阐明这种药物代谢多态性的分子遗传基础。对所有可用的重组UGT同工型进行R-和S-奥沙西泮葡萄糖醛酸化活性筛选。然后在代表性的人肝微粒体(HLM)和表现出显著活性的UGT中测定酶动力学参数。在评估的12种不同UGT中,只有UGT2B15表现出显著的S-奥沙西泮葡萄糖醛酸化。此外,UGT2B15的表观K(m)(29 - 35 microM)与HLM测定的值(43 - 60 microM)相似。相比之下,R-奥沙西泮由UGT1A9和UGT2B7进行葡萄糖醛酸化。尽管HLM的表观K(m)值(256 - 303 microM)与UGT2B7(333 microM)最为相似,而非UGT1A9(12 microM),但UGT1A9的内在清除率值比UGT2B7高10倍。一种常见的基因变异导致UGT2B15蛋白第85位出现天冬氨酸(UGT2B151)或酪氨酸(UGT2B152)。过表达UGT2B151的人胚肾(HEK)-293细胞微粒体显示出的S-奥沙西泮葡萄糖醛酸化活性比UGT2B152微粒体高5倍。对于其他底物,包括丁香酚、柚皮素、4-甲基伞形酮和雄甾烷-3α-二醇,也获得了类似结果。总之,S-奥沙西泮由UGT2B15进行立体选择性葡萄糖醛酸化,而R-奥沙西泮由多种UGT同工型进行葡萄糖醛酸化。与UGT2B15基因相关的等位基因变异可能解释了人类中S-奥沙西泮葡萄糖醛酸化的多态性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验